The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome
NCT ID: NCT07026890
Last Updated: 2025-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2025-07-16
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits.
The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part.
The total duration of your participation is 5 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders With Behavioral Disturbances
NCT07264439
Tolerance for Using Virtual Reality With Subjects Living in Accommodation Establishment for the Elderly Dependent (EHPAD)
NCT04365829
Personalized Virtual Reality Naturalistic Scenarios in Cognitive Impairment
NCT05863065
Virtual Nature as a Health-promoting Intervention for Nursing Home Residents With Dementia
NCT06923358
Enhanced Medical Rehabilitation in Older Adults
NCT02114879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: conventional rehabilitation + 3 virtual reality sessions
Evaluation visits
3 assessment visits (initial (V1), intermediate (V2) and final (V3).
A series of motor assessments carried out by the physiotherapist:
* Timed Up and Go Test (TUG)
* 10 m walk test (TM10)
* Functional Reach Test (FRT)
* Minimum Motor Test (TMM)
* 10 m walk test combined with a verbal task such as naming different animals
Rehabilitation sessions
Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.
Virtual reality sessions
3 virtual reality sessions per week, each lasting 30 minutes.
Control: conventional rehabilitation + 3 additional rehabilitation sessions
Evaluation visits
3 assessment visits (initial (V1), intermediate (V2) and final (V3).
A series of motor assessments carried out by the physiotherapist:
* Timed Up and Go Test (TUG)
* 10 m walk test (TM10)
* Functional Reach Test (FRT)
* Minimum Motor Test (TMM)
* 10 m walk test combined with a verbal task such as naming different animals
Rehabilitation sessions
Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.
Additional rehabilitation sessions
3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation visits
3 assessment visits (initial (V1), intermediate (V2) and final (V3).
A series of motor assessments carried out by the physiotherapist:
* Timed Up and Go Test (TUG)
* 10 m walk test (TM10)
* Functional Reach Test (FRT)
* Minimum Motor Test (TMM)
* 10 m walk test combined with a verbal task such as naming different animals
Rehabilitation sessions
Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.
Virtual reality sessions
3 virtual reality sessions per week, each lasting 30 minutes.
Additional rehabilitation sessions
3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person aged ≥ 65 years;
* With a proven diagnosis of motor maladjustment syndrome;
* Hospitalised in a geriatric care unit;
* Able to understand a simple instruction and answer a closed question;
Exclusion Criteria
* Person subject to a legal protection measure (curatorship, guardianship)
* Person subject to a judicial protection measure
* An adult who is incapable or unable to give consent
* Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
* Anyone with a severe visual and/or hearing impairment
* Any person with a behavioural disorder (agitation, aggressiveness)
* Any person with a severe walking or balance problem that makes motor exercises unsuitable
* Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
* Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
* Inability to use arm for pointing
* Persons susceptible to migraines
* Non-French speakers
* Anyone with an inter-pupillary distance outside the range of possible helmet adjustments
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIPANDA 2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.